Keyphrases
Ovarian Cancer
100%
Therapeutic Outcome
100%
Survival Rate
28%
Screening Tool
14%
Clinical Trials
14%
Chemotherapy
14%
Malignancy
14%
On-state Current
14%
Translational Research
14%
Drug Resistance
14%
Cancer Therapeutics
14%
Cancer Cells
14%
Advanced Stage
14%
Therapeutic Response
14%
Poor Survival
14%
Radiotherapy
14%
Platinum-based Chemotherapy
14%
Debulking Surgery
14%
Immunomodulation
14%
Relapse Rate
14%
Treatment Trials
14%
High Morbidity
14%
Poor Quality of Life
14%
Morbidity Rate
14%
Resistance to Chemotherapy
14%
Exhaustive Search
14%
Toxicity Resistance
14%
Drug Burden
14%
Chemo Drugs
14%
Multidisciplinary Approach
14%
Platinum-based Agents
14%
Further Treatment
14%
Early-stage Detection
14%
Clinical Trial Information
14%
Therapeutic Management
14%
Financial Burden
14%
Gynecological Tumors
14%
Chemotherapy Drugs
14%
Medicine and Dentistry
Ovarian Cancer
100%
Chemotherapy
42%
Clinical Trial
28%
Survival Rate
28%
Biological Marker
14%
Treatment Response
14%
Cancer
14%
Cancer Cell
14%
Quality of Life
14%
Recurrence Risk
14%
Drug Resistance
14%
Morbidity
14%
Debulking Surgery
14%
Cytoreductive Surgery
14%
Radiation Therapy
14%
Clinical Translational Research
14%
Therapeutic Management
14%
Female Genital Tract Tumor
14%
Immunomodulation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Chemotherapy
42%
Clinical Trial
28%
Survival Rate
28%
Biological Marker
14%
Malignant Neoplasm
14%
Drug Resistance
14%
Clinical Research
14%
Recurrence Risk
14%
Morbidity
14%
Immunomodulation
14%
Female Genital Tract Tumor
14%